Special issue on robust multivariate analysis and classification

M. Riani,A. Cerioli,Bruno Chiandotto

DOI: https://doi.org/10.1007/s10260-006-0040-6

2007-01-30

Abstract:

What problem does this paper attempt to address?

Initiation of non-invasive ventilation in amyotrophic lateral sclerosis and clinical practice guidelines: Single-centre, retrospective, descriptive study in a national reference centre

Marjolaine Georges,Jean-Louis Golmard,Claudia Llontop,Amr Shoukri,François Salachas,Thomas Similowski,Capucine Morelot-Panzini,Jésus Gonzalez-Bermejo

DOI: https://doi.org/10.1080/21678421.2016.1236817

2016-12-15

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Abstract:In amyotrophic lateral sclerosis (ALS), respiratory muscle weakness leads to respiratory failure. Non-invasive ventilation (NIV) maintains adequate ventilation in ALS patients. NIV alleviates symptoms and improves survival. In 2006, French guidelines established criteria for NIV initiation based on limited evidence. Their impact on clinical practice remains unknown. Our objective was to describe NIV initiation practices of the main French ALS tertiary referral centre with respect to guidelines. In this retrospective descriptive study, 624 patients followed in a single national reference centre began NIV between 2005 and 2013. We analysed criteria used to initiate NIV, including symptoms, PaCO2, forced vital capacity, maximal inspiratory pressures and time spent with SpO2 <90% at night. At NIV initiation, 90% of patients were symptomatic. Median PaCO2 was 48 mmHg. The main criterion to initiate NIV was 'symptoms' followed by 'hypercapnia' in 42% and 34% of cases, respectively. NIV was initiated on functional parameters in only 5% of cases. Guidelines were followed in 81% of cases. In conclusion, despite compliance with French guidelines, the majority of patients are treated at the stage of symptomatic daytime hypoventilation, which suggests that NIV is initiated late in the course of ALS. Whether this practice could be improved by changing guidelines or increasing respiratory-dedicated resources remains to be determined.

clinical neurology
Quantum phase slips in a confined geometry

S. Khlebnikov

DOI: https://doi.org/10.1103/PhysRevB.77.014505

2007-09-12

Abstract:We consider tunneling of vortices across a superconducting film that is both narrow and short (and connected to bulk superconducting leads at the ends). We find that in the superconducting state the resistance, at low values of the temperature $(T)$ and current, does not follow the power-law dependence on $T$ characteristic of longer samples but is exponential in $1∕T$. The coefficient of $1∕T$ in the exponent depends on the length or, equivalently, the total normal-state resistance of the sample. These conclusions persist in the one-dimensional limit, which is similar to the problem of quantum phase slips in an ultranarrow short wire.
Factors associated with survival after early at-home NIV initiation in ALS patients

Thomas Réginault,P. Wibart,S. Mathis,G. Le Masson,O. Pillet,L. Grassion

DOI: https://doi.org/10.1007/s00415-024-12523-w

2024-06-25

Journal of Neurology

Abstract:Background The initiation of early non-invasive ventilation (NIV) often involves a careful balance between tolerance and effectiveness. In amyotrophic lateral sclerosis (ALS) patients, the establishment of a strategy, including the decision to focus on adhering to a cut-off, setting specific targets, or correcting all events, is crucial. Objective To identify factors at 1 month after early at-home NIV initiation that are associated with improved survival in ALS patients. We explored the impacts of adherence (ADH), quality of treatment, and NIV parameters at 1 month after early at-home NIV initiation on patient survival. Methods We conducted a retrospective study of 184 ALS patients at the Bordeaux ALS Centre for whom NIV was initiated between September 2017 and June 2021, and we collected data for a minimum period of 2 years after the last patient included. The primary outcome was the risk of death according to baseline characteristics of our population and the NIV parameters and monitoring during the early NIV initiation period. The secondary outcomes were association with NIV ADH during the early NIV initiation period on prognosis, and NIV ADH cut-off for good versus poor prognosis. Results Among the 178 ALS patients analysed, we found that quality of NIV treatment and device settings did not significantly influence prognosis. However, low ADH was significantly associated with a higher risk of death. The use of NIV for > 5 h/day during the early NIV initiation period was linked to a decreased risk of death [hazard ratio = 0.4; 95% confidence interval: 0.27–0.9]. Conclusion The use of NIV for > 5 h/day during the early NIV initiation period was associated with increased survival.

clinical neurology
Noninvasive mechanical ventilation assistance in amyotrophic lateral sclerosis: a systematic review

Carolina da Cunha-Correia,Mylana Dandara Pereira Gama,Pedro Nogueira Fontana,Francisca Goreth Malheiro Moraes Fantini,Gilmar Fernandes Prado,Mário Emílio Teixeira Dourado,Paulo Adriano Schwingel,Mário Emílio Teixeira Dourado Júnior

DOI: https://doi.org/10.1590/1516-3180.2022.0470.r1.100423

2024-01-01

Sao Paulo Medical Journal

Abstract:BACKGROUND: Respiratory failure is the most common cause of death in patients with amyotrophic lateral sclerosis (ALS), and morbidity is related to poor quality of life (QOL). Non-invasive ventilation (NIV) may be associated with prolonged survival and QOL in patients with ALS.OBJECTIVES: To assess whether NIV is effective and safe for patients with ALS in terms of survival and QOL, alerting the health system.DESIGN AND SETTING: Systematic review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses reporting standards using population, intervention, comparison, and outcome strategies.METHODS: The Cochrane Library, CENTRAL, MEDLINE, LILACS, EMBASE, and CRD databases were searched based on the eligibility criteria for all types of studies on NIV use in patients with ALS published up to January 2022. Data were extracted from the included studies, and the findings were presented using a narrative synthesis.RESULTS: Of the 120 papers identified, only 14 were related to systematic reviews. After thorough reading, only one meta-analysis was considered eligible. In the second stage, 248 studies were included; however, only one systematic review was included. The results demonstrated that NIV provided relief from the symptoms of chronic hypoventilation, increased survival, and improved QOL compared to standard care. These results varied according to clinical phenotype.CONCLUSIONS: NIV in patients with ALS improves the outcome and can delay the indication for tracheostomy, reducing expenditure on hospitalization and occupancy of intensive care unit beds.SYSTEMATIC REVIEW REGISTRATION: PROSPERO database: CRD42021279910 - https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=279910.

medicine, general & internal
Acute and Sub-Acute Toxicity Studies of Plumeria alba Linn. (Apocynaceae) Hydroalcoholic Extract in Rat

K. Z. Tessou,P. Lawson-Evi,K. Metowogo,Aboudoulatif Diallo,K. Eklu-Gadegkeku,K. Aklikokou,M. Gbéassor

2013-12-01

Abstract:Plumeria alba Linn (Apocynaceae) is used in Togolese traditional medicine to treat diabetes mellitus and wounds. The present investigation was carried out to evaluate the toxicity of hydroalcoholic extract of Plumeria alba roots in Sprague Dawley rats. The acute toxicity test was conducted by administering orally dose of 5 g/Kg. General behavior and mortality were examined for up to 14 days. The sub-acute toxicity test was performed by daily gavage at 250, 500 and 1000 mg/Kg for 28 days. Body weight and blood glucose were measured weekly. Hematological and biochemical parameters, relative organ weight were determined at the end of the 28 days administration. In acute study, no adverse effect of the extract was observed at 5.0 g/Kg. Sub-acute oral administration of the extract at the dose up to 1000 mg/Kg did not induce death or significant changes in body weight, relative weight of vital organs, hematological parameters and was not associated with liver and kidney toxicity.
Transthyretin amyloidosis (serine 44) with headache, hearing loss, and peripheral neuropathy

C. Klein,M. Nakumura,D. Jacobson,M. Lacy,M. Benson,R. Petersen

DOI: https://doi.org/10.1212/WNL.51.5.1462

IF: 9.9

1998-11-01

Neurology

Abstract:A 32-year-old man of Irish descent presented with severe progressive headache and sensorineural hearing loss. MRI/magnetic resonance angiography head scans were normal. A length-dependent sensorimotor peripheral neuropathy with autonomic dysfunction predated these symptoms. Systemic organ involvement and transthyretin (TTR) amyloid immunostaining of bone marrow and fat aspirate were documented. Direct DNA sequencing revealed both the normal TTT (phenylalanine) and a new variant TCT (serine) at position 44 of the TTR gene. This case expands the genotypic and phenotypic variability within TTR amyloidosis.
Hyponatremia in Preterm Neonates: Not a Benign Condition

M. Moritz,J. Ayus

DOI: https://doi.org/10.1542/peds.2009-1869

2009-11-01

PEDIATRICS

Abstract:In the October 2009 issue of Pediatrics , Baraton et al1 revealed that large variations in serum sodium (SNa) concentration in the very preterm neonate ( 150 mEq/L) was 13 mEq/L had hyponatremia, with an average nadir SNa concentration of 126 mEq/L. Overcorrection of hyponatremia did not seem to be a factor for this group, because the change in SNa concentration averaged 6 mEq/L per day, with the variation in SNa concentration averaging 20 mEq/L over 5 days. There are data to suggest that hyponatremia has deleterious consequences in the preterm neonate. Preterm neonates on sodium-restricted diets have an increased incidence of hyponatremia with … Address correspondence to Michael L. Moritz, MD, Children's Hospital of Pittsburgh of UPMC, Division of Nephrology, 45th Street and Penn Avenue, Pittsburgh, PA 15201. E-mail: moritzml{at}upmc.edu
Effects of non-invasive ventilation on objective sleep and nocturnal respiration in patients with amyotrophic lateral sclerosis

Matthias Boentert,Inga Brenscheidt,Christian Glatz,Peter Young

DOI: https://doi.org/10.1007/s00415-015-7822-4

2015-06-17

Journal of Neurology

Abstract:In amyotrophic lateral sclerosis (ALS), non-invasive ventilation (NIV) is indicated if sleep-disordered breathing (SDB), daytime hypercapnia, or significant diaphragmatic weakness is present. We investigated both short-term and long-term effects of NIV on objective measures of sleep and nocturnal respiration in patients with ALS. Polysomnography (PSG) and transcutaneous capnography were conducted for diagnosis of SDB (T0), for treatment initiation (T1), and follow-up 3, 9, and 15 months later (T2, T3, and T4, respectively). Records from 65 patients were retrospectively analyzed at T0 and T1. At subsequent timepoints, the number of full data sets decreased since follow-up sleep studies frequently included polygraphy rather than PSG (T2, 38 patients, T3, 17 patients, T4, 11 patients). At T0, mean age was 63.2 years, 29 patients were female, and 22 patients had bulbar ALS. Immediate sequelae of NIV initiation included significant increases of slow wave sleep, rapid eye movement sleep, and oxygen saturation. Mean apnea–hypopnea index, respiratory rate, and the maximum transcutaneous carbon dioxide tension were reduced. At T2–T4, normoxia and normocapnia were preserved. Sleep quality measures showed no alteration as diurnal use of NIV gradually increased reflecting disease progression. In contrast to previous reports, improvement of sleep and respiratory outcomes was found in both non-bulbar and bulbar patients. NIV significantly improves objective sleep quality and SDB in the first night of treatment in patients with bulbar and non-bulbar ALS. NIV warrants nocturnal normoventilation without deterioration of sleep quality in the long run with only minor changes to ventilator settings.

clinical neurology
Characterization of mu, kappa, and delta opioid binding in amphibian whole brain tissue homogenates.

L. C. Newman,Steven S. Sands,D. Wallace,C. Stevens

Journal of Pharmacology and Experimental Therapeutics

Abstract:Opioid agonists produce analgesia in mammals through the activation of mu, kappa, or delta opioid receptors. Previous behavioral and binding studies from our laboratory using an amphibian model suggested that mu, kappa, or delta opioid agonists may activate a single type of opioid receptor in the grass frog, Rana pipiens. In the present study, kinetic, saturation, and competitive binding profiles for three opioid radioligands, [(3)H]DAMGO ([D-Ala(2),N-Me-Phe(4),Gly(5)-ol]-enkephalin) (mu-selective), [(3)H]U65953 [(5 alpha, 7 alpha,8 beta)-(+)-N-methyl-N-[7-(1-pyrrolidinyl)-1-oxaspiro[4.5]dec-8-yl]-benzeneacetamide] (kappa-selective), and [(3)H]DPDPE ([D-Pen(2),D-Pen(5)]-enkephalin) (delta-selective) were determined using frog whole brain homogenates. Kinetic analyses and experimentally derived values from saturation experiments gave affinity constants (K(D)) in the low nanomolar range. The density of opioid binding sites (B(max)) was 224.4, 118.6, and 268.9 fmol/mg for mu, kappa, and delta opioid radioligands, respectively. The affinity values did not significantly differ among the three opioid radioligands, but the kappa radioligand bound to significantly fewer sites than did the mu or delta radioligands. K(i) values for unlabeled mu, kappa, and delta competitors, including highly selective opioid antagonists, were consistent with each radioligand selectivity profile. The present data suggest that mu, kappa, and delta opioid radioligands bind to distinct opioid receptors in amphibians that are surprisingly similar to those found in mammalian brain.
NIV@Home: a pilot randomized controlled trial of in-home noninvasive ventilation initiation compared to a single-day admission model

Nicole L. Sheers,Liam M. Hannan,Linda Rautela,Marnie Graco,Jennifer Jones,Sarah Retica,Krisha Saravanan,Nicola Burgess,Rebekah McGaw,Ashleigh Donovan,Talia Clohessy,Caroline Chao,Cameron Charles,Mark E. Howard,David J. Berlowitz

DOI: https://doi.org/10.1080/21678421.2024.2416668

2024-10-23

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Abstract:Objective : Noninvasive ventilation (NIV) is the primary treatment for respiratory insufficiency in neuromuscular disease. NIV implementation is usually conducted within hospitals; however, in-home implementation with intensive follow-up is an effective alternative. This pilot study aimed to assess model feasibility, acceptability, and NIV usage at 12-weeks after a single visit in-home implementation of NIV with remote monitoring follow-up (NIV@Home) compared to an in-hospital day admission NIV initiation plus planned polysomnography (Usual care). Methods : A single-blinded randomized controlled trial (www.anzctr.org.au ACTRN12620000682943) of adults with neuromuscular disease referred for NIV implementation. Participants were stratified by disease (MND or Other diagnoses) and bulbar symptoms before randomization to NIV@Home or Usual care, with follow-up at 12-weeks. The primary outcome was NIV usage. Secondary outcomes included feasibility, health-related quality of life, symptoms, carer burden, and NIV experience (semi-structured qualitative interviews). Results : Twenty-three participants (MND bulbar = 9, MND non-bulbar = 11, Other = 3) were randomized (NIV@Home = 9). No statistical differences were observed in the percentage of MND participants using NIV for >4 hours/day (NIV@Home = 33% vs. Usual care = 60%, p = 0.370), average use (NIV@Home = 2.4 [1.5–9.3] vs. 5.3 [1.8–7.0] hours/day, p = 0.568), or secondary outcomes. In-home NIV implementation was feasible and safe but took more therapist time (NIV@Home = 278 [270–305] vs. 172 [130–200] minutes, p < 0.001). Participants in the NIV@Home group reported substantial advantages to receiving care in home. Conclusion : In-home NIV implementation is feasible and acceptable to people with MND but requires more therapist time. Larger studies are required to determine whether there are clinically important differences between this model of NIV initiation and a traditional hospital-based model.

clinical neurology
Defining successful non-invasive ventilation initiation: Data from a real-life cohort

Grégoire Jolly,Léa Razakamanantsoa,Emeline Fresnel,Zouhaier Gharsallaoui,Antoine Cuvelier,Maxime Patout

DOI: https://doi.org/10.1111/resp.14118

IF: 6.9

Respirology

Abstract:Background and objective: When home non-invasive ventilation (NIV) is initiated, five goals need to be achieved: a daily use >4 h/day, an improvement in gas exchange, health-related quality of life (HRQL) and sleep quality without side effects. Our aim was to assess how frequently these five goals were reached and the factors predictive of achievement. Methods: We conducted a monocentric cohort study that included patients electively established on home NIV over 2 years. HRQL was assessed at baseline and follow-up by the Severe Respiratory Insufficiency questionnaire. Adequate initiation was defined as the achievement of at least three of five goals and successful initiation as the achievement of all. Results: Two-hundred and fifty patients were included at baseline. NIV was initiated for: obesity hypoventilation syndrome (n = 95; 38%), neuromuscular disease (n = 70; 28%), chronic obstructive pulmonary disease (n = 66; 26%) and chest wall disease (n = 19; 8%). At follow-up, measures of all five goals were available in 141 (56%) patients. NIV initiation was adequate for 96 (68%) patients and successful for 12 (9%) patients. In multivariate analysis, a tidal volume ≥ 7.8 ml/kg of ideal body weight was associated with an increased likelihood of adequate NIV initiation (hazard ratio: 5.765 [95% CI:1.824-18.223], p = 0.006]. Improvement in daytime partial arterial carbon dioxide pressure (PaCO2 ) was not correlated to improvement in HRQL or sleep quality. Severe to very severe NIV-related side effects occurred in 114 (47%) patients and were associated with higher daytime PaCO2 (6.35 ± 1.08 vs. 5.92 ± 0.79 kPa, p < 0.001). Conclusion: Successful home NIV initiation is rarely achieved in real life. HRQL and NIV tolerance should be assessed to improve patient-centred outcomes.
Giving Breath to Motor Neurons: Noninvasive Mechanical Ventilation Slows Disease Progression in Amyotrophic Lateral Sclerosis

Maurizio Grassano,Emanuele Koumantakis,Umberto Manera,Antonio Canosa,Rosario Vasta,Francesca Palumbo,Giuseppe Fuda,Paolina Salamone,Giulia Marchese,Federico Casale,Lorena Charrier,Gabriele Mora,Cristina Moglia,Andrea Calvo,Adriano Chiò

DOI: https://doi.org/10.1002/ana.26875

IF: 11.2

2024-01-31

Annals of Neurology

Abstract:Objective Noninvasive mechanical ventilation (NIMV) improves amyotrophic lateral sclerosis (ALS) quality of life and survival. However, data about its effect on disease progression are still lacking. Here, we test whether NIMV use changed the rate of functional decline among ALS patients. Methods In this retrospective observational study, we included 448 ALS patients followed up at the ALS Center in Turin, Italy, who underwent NIMV during the disease course. The primary outcome was the change in functional decline after NIMV initiation adjusting for covariates. Functional decline was based on the nonrespiratory items of the Amyotrophic Lateral Sclerosis Functional Rating Scale–Revised (ALSFRS‐R). Results NIMV initiation resulted in a slower functional decline (mean improvement = 0.16 points per month, 95% confidence interval = 0.12–0.19, p

neurosciences,clinical neurology
Predictors for successful non-invasive ventilation in patients with neuralgic amyotrophy and phrenic nerve involvement

Sprooten,R. T. M.,Hendrikx,A. B. R.,Vosse,B. A. H.,Steyns,S. C. M.,Van Kuijk,S. M. J.,Hoeijmakers,J. G. J.,Franssen,F. M. E.

DOI: https://doi.org/10.1183/13993003.congress-2024.pa5287

IF: 24.3

2024-11-01

European Respiratory Journal

Abstract:Background Patients with neuralgic amyotrophy (NA) and involvement of the phrenic nerve are mostly symptomatic and might benefit from home non-invasive ventilation (NIV). However, predictors of successful NIV in these patients are currently unknown. This study aimed to study the efficacy and potential predictors for successful home NIV in patients with NA. Methods Data of all NA patients initiated on chronic NIV by the Centre of Home Mechanical Ventilation of Maastricht UMC+ between September 2008 and April 2023 were retrospectively analyzed. Primary outcome was treatment success, defined as chronic continuation of NIV or successful step-down from NIV. Univariate and multivariate analyses using Cox proportional hazard models were used for statistical analysis of predictors of success. Results 54 patients (mean age 62.5±10.9y, 72.2% males) were included. Mean delta FVC with posture at NIV initiation was 35.1±19.6 %pred. Mean compliance to NIV of 6.37 [3.55–8.11] hours per day. 38 (70.4%) patients continued to use NIV over a mean of 4.9 years of follow-up. Six (11%) stepped-down from NIV, accompanied by improvement in symptoms and lung function. Delta FVC(pred%) at NIV initiation was an independent factor for successful NIV (HR=0.947; confidence interval=[0.91–0.99]). During follow-up, delta FVC(pred%) declined, particularly in the first two years after initiation of NIV. Conclusion In 70% of patients with NA with diaphragm involvement and initiated on home NIV, the intervention was successful according to the used definition. This study identified delta FVC(pred%) at start as a clinical important independent predictor for a successful NIV in these patients.

respiratory system
Effect to prognosis by early or late use of noninvasive positive pressure ventilation in patients with amy- otrophic lateral sclerosis

Pan DENG,Dong-sheng FAN

DOI: https://doi.org/10.3969/j.issn.1674-7372.2015.09.003

2015-01-01

Abstract:ObjectiveTo observe the effect to survival time of amyotrophic lateral sclerosis (ALS) patients by early or late onset use of noninvasive positive pressure ventilation (NIPPV).MethodRetrospectively analyzed the patients in the database of ALS patients admitted from outpatient in neurology department of Peking University Third Hospital from 2003 to 2012. Chose the patients who were diagnosed as ALS according to the Escorial Criteria and whose diagnosing grade was definite, probable or possible, another criteria was that their diagnosis as ALS didn’t change during our follow-up, used the same designed recording book to record their clinic materials, and followed up them by phone every 3 months and also recorded the related clinic materials.ResultIn the database of 1697 ALS patients in our department from 2003 to 2012, 208 patients used NIPPV. We deifned the patients who began to use NIPPV when their FVC≥50% or they didn’t have respiratory symptom as early-onset users, and those who began to use NIPPV when their FVC<50% or they had respiratory symptom as late-onset users. Then we analyzed the 147 ALS patients (47 early-onset users, 100 late-onset users) who had complete data and use NIPPV, and we found there was signiifcant difference between early-onset and late-onset users in these factors, namely, subtype of diagnosis, subtype of diagnosis, onset site, delay time of diagnosis, exist bulbar symptom and BMI when patients began to use NIPPV. So we matched the 47 early-onset users to 47 late-onset users and divided them into groups with or without bulbar symptom when they began to use NIPPV in order to make sure that every factor was compatible. We analyzed the data above using the single-factor analysis and multiple-factor analysis and foundthat survival time was compatible between early-onset and late-onset users.ConclusionUsing FVC and respiratory symptom as criteria to deifne early-onset and late-onset users, our retrospective nonsynchronous control research suggested that early-onset users of NIPPV didn’t extend their survival time than late-onset users.
Unstable control of breathing can lead to ineffective noninvasive ventilation in amyotrophic lateral sclerosis

Jesús Sancho,Enric Burés,Santos Ferrer,Ana Ferrando,Pilar Bañuls,Emilio Servera

DOI: https://doi.org/10.1183/23120541.00099-2019

2019-07-22

Abstract:Upper airway obstruction with decreased central drive (ODCD) is one of the causes of ineffective noninvasive ventilation (NIV) in amyotrophic lateral sclerosis (ALS). The aim of this study is to determine the mechanism responsible for ODCD in ALS patients using NIV. This is a prospective study that included ALS patients with home NIV. Severity of bulbar dysfunction was assessed with the Norris scale bulbar subscore; data on upper or lower bulbar motor neuron predominant dysfunction on physical examination were collected. Polysomnography was performed on every patient while using NIV and the ODCD index (ODCDI: number of ODCD events/total sleep time) was calculated. To determine the possible central origin of ODCD, controller gain was measured by inducing a hypocapnic hyperventilation apnoea. Sonography of the upper airway during NIV was performed to determine the location of the ODCD. 30 patients were enrolled; three (10%) had ODCDI >5 h-1. The vast majority of ODCD events were produced during non-rapid eye movement sleep stages and were a consequence of an adduction of the vocal folds. Patients with ODCDI >5 h-1 had upper motor neuron predominant dysfunction at the bulbar level, and had greater controller gain (1.97±0.33 versus 0.91±0.36 L·min-1·mmHg-1; p<0.001) and lower carbon dioxide (CO2) reserve (4.00±0.00 versus 10.37±5.13 mmHg; p=0.043). ODCDI was correlated with the severity of bulbar dysfunction (r= -0.37; p=0.044), controller gain (r=0.59; p=0.001) and CO2 reserve (r= -0.35; p=0.037). ODCD events in ALS patients using NIV have a central origin, and are associated with instability in the control of breathing and an upper motor neuron predominant dysfunction at the bulbar level.
Continuous noninvasive ventilatory support outcomes for patients with neuromuscular disease: a multicenter data collaboration

M R Gonçalves,J R Bach,Y Ishikawa,L Saporito,J C Winck,International Study Group on Continuous Noninvasive Ventilatory Support in Neuromuscular Disease (CNVSND)

DOI: https://doi.org/10.1016/j.pulmoe.2021.06.007

IF: 11.7

Pulmonology

Abstract:Background: Typically, patients with progressive neuromuscular disorders (NMDs) develop acute respiratory failure (ARF), are intubated, and when failing spontaneous breathing trials (SBTs) undergo a tracheotomy and receive tracheostomy mechanical ventilation (TMV). However, increasing numbers of patients use nasal noninvasive ventilation (NIV), initially for sleep and this is extended to continuous dependence (CNVS). This can be used as a strategy to assist in successful extubation . We retrospectively reviewed 19 centers offering CNVS and mechanical insufflation-exsufflation (MI-E) as an alternative to TMV. Methods: Centers with publications or presentations concerning CNVS outcomes data were pooled for amyotrophic lateral sclerosis (ALS), Duchenne muscular dystrophy (DMD), and spinal muscular atrophy type 1 (SMA1). Progression to CNVS dependence without hospitalization, duration of dependence, and extubations and decannulations to CNVS were recorded. Prolongation of life was defined by duration of CNVS dependence without ventilator free breathing ability (VFBA). Results: There were 1623 part time (<23 h/day) NVS users with ALS, DMD, and SMA1 from 19 centers in 16 countries of whom 761 (47%) were CNVS dependent for 2218 patient-years. This included: 335 ALS patients for a mean 1.2 ± 1.0 (range to 8) years each; 385 DMD patients for 5.4 ± 1.6 (range to 29) years; and 41 SMA1 patients for 5.9 ± 1.8 (range to 20) years. Thirty-five DMD and ALS TMV users were decannulated to CNVS and MI-E. At data collection 494 (65%) patients were CNVS dependent but 110 (74 of whom with bulbar ALS), had undergone tracheotomies. Conclusions: ALS, DMD, and SMA1 patients can become CNVS dependent without requiring hospitalization but CNVS cannot be used indefinitely for many patients with advanced upper motor neuron diseases.
Partnership at the forefront of change: documenting the transformation of child and youth mental health services in quebec.

L. Nadeau,Annie Jaimes,C. Rousseau,G. Papazian-Zohrabian,Kateri Germain,Joanna Broadhurst,A. Battaglini,T. Measham

2012-05-01

Abstract:OBJECTIVE The Quebec Plan d'action en santé mentale (PASM) (Mental Health Action Plan) reform, a major transformation of the province's mental health care system, has put primary care rather than hospital-based care at the forefront of mental health service delivery. This study documents perceptions of changes in child and youth mental health (CYMH) services following the reform, as well as facilitators and obstacles to collaboration and partnership in CYMH services, and the specific challenges related to collaboration and partnership when servicing multi-ethnic populations. METHODS This qualitative participatory research study collected data using semi-structured individual interviews, focus groups and participant observation in community-based health and social service institutions. Thematic analysis was performed. RESULTS The reform process encountered challenges in building a common culture of care within and between institutions, while collaboration and partnership evolved in a positive direction throughout the study. Study results highlighted the importance of fostering communication at all levels. Collaboration and partnership was facilitated by opportunities for clinical discussions, dialogue on models of care, harmonizing administrative and clinical priorities, and involving key actors and structures. The results revealed difficulties in implementing multidisciplinary work and in negotiating partners' responsibilities. Quality of partnership and collaboration appeared particularly crucial in providing optimal care to vulnerable families, including migrants. CONCLUSION The PASM reform involved a major and challenging transformation in CYMH services. Continuous dialogue through time and leadership sharing appeared promising to foster this transformation.
Long term non-invasive ventilation in the community for patients with musculoskeletal disorders: 46 year experience and review

A Baydur,E Layne,H Aral,N Krishnareddy,R Topacio,G Frederick,W Bodden

DOI: https://doi.org/10.1136/thorax.55.1.4

Thorax

Abstract:Background: A study was undertaken to assess the long term physiological and clinical outcome in 79 patients with musculoskeletal disorders (73 neuromuscular, six of the chest wall) who received non-invasive ventilation for chronic respiratory failure over a period of 46 years. Methods: Vital capacity (VC) and carbon dioxide tension (PCO(2)) before and after initiation of ventilation, type and duration of ventilatory assistance, the need for tracheostomy, and mortality were retrospectively studied in 48 patients who were managed with mouth/nasal intermittent positive pressure ventilation (M/NIPPV) and 31 who received body ventilation. The two largest groups analysed were 45 patients with poliomyelitis and 15 with Duchenne's muscular dystrophy. Twenty five patients with poliomyelitis received body ventilation (for a mean of 290 months) and 20 were supported by M/NIPPV (mean 38 months). All 15 patients with Duchenne's muscular dystrophy were ventilated by NIPPV (mean 22 months). Results: Fourteen patients with poliomyelitis on body ventilation (56%) but only one on M/NIPPV, and 10 of 15 patients (67%) with Duchenne's muscular dystrophy eventually received tracheostomies for ventilatory support. Five patients with other neuromuscular disorders required tracheostomies. Twenty of 29 tracheostomies (69%) were provided because of progressive disease and hypercarbia which could not be controlled by non-invasive ventilation; the remaining nine were placed because of bulbar dysfunction and aspiration related complications. Nine of 10 deaths occurred in patients on body ventilation (six with poliomyelitis), although the causes of death were varied and not necessarily related to respiratory complications. A proportionately greater number of patients on M/NIPPV (67%) reported positive outcomes (improved sense of wellbeing and independence) than did those on body ventilation (29%, p<0.01). However, other than tracheostomies and deaths, negative outcomes in the form of machine/interface discomfort and self-discontinuation of ventilation also occurred at a rate 2.3 times higher than in the group who received body ventilation. None of the six patients with chest wall disorders (all on M/NIPPV) required tracheostomy or died. Hospital admission rates increased nearly eightfold in patients receiving body ventilation (all poliomyelitis patients) compared with before ventilation (p<0.01) while in those supported by M/NIPPV they were reduced by 36%. Conclusions: Non-invasive ventilation (NIV) in the community over prolonged periods is a feasible although variably tolerated form of management in patients with neuromuscular disorders. While patients who received body ventilation were followed the longest (mean 24 years), the need for tracheostomy and deaths occurred more often in this group (most commonly in the poliomyelitis patients). Despite a number of discomforts associated with M/NIPPV, a larger proportion of patients experienced improved wellbeing, independence, and ability to perform daily activities.
Initiation of Chronic Non-invasive Ventilation

Marieke L Duiverman,Filipa Jesus,Gerrie Bladder,Peter J Wijkstra

DOI: https://doi.org/10.1016/j.jsmc.2024.04.006

Abstract:Initiation of home non-invasive ventilation (NIV) requires careful consideration of the patient's condition, motivation, expectations, wishes, and social circumstances. The decision to start NIV depends on a combination of factors including patient symptoms and objective evidence of nocturnal hypoventilation. A solid understanding of the underlying pathophysiology is key to a systematic and well-balanced clinical approach to titrating NIV. The location where NIV is initiated is not the most relevant issue, provided that it is a comfortable, safe environment in which adequate monitoring can be assured. The majority of patients prefer their own home for treatment initiation.
Delivery of noninvasive ventilation to people living with motor neuron disease in the UK

Lucy S Musson,Susan K Baxter,Paul Norman,David O'Brien,Mark Elliott,Stephen Bianchi,Georgios Kaltsakas,Christopher J McDermott,Theocharis Stavroulakis,Esther V Hobson

DOI: https://doi.org/10.1183/23120541.00388-2022

2023-03-27

Abstract:Objective: Noninvasive ventilation (NIV) improves survival and quality of life in motor neuron disease (MND), but many patients fail to receive effective ventilation. This study aimed to map the respiratory clinical care for MND patients at a service and individual healthcare professional (HCP) level to understand where attention may be needed to ensure all patients receive optimal care. Methods: Two online surveys of HCPs working with MND patients in the UK were conducted. Survey 1 targeted HCPs providing specialist MND care. Survey 2 targeted HCPs working in respiratory/ventilation services and community teams. Data were analysed using descriptive and inferential statistics. Results: Responses from 55 HCPs providing specialist MND care who worked at 21 MND care centres and networks and 13 Scotland Health Boards were analysed from Survey 1. Responses from 85 HCPs from respiratory/ventilation services and 73 HCPs from community teams, representing 97 services, were analysed from Survey 2. Significant differences in practice were identified at each stage of the respiratory care pathway as well as evidence of the need for improvement. This included when patients were referred to respiratory services, the time taken waiting to commence NIV, the availability of sufficient NIV equipment and provision of services, particularly out of hours. Conclusion: We have highlighted significant disparity in MND respiratory care practices. Increased awareness of the factors that influence NIV success and the performance of individuals and services is important for optimal practice.

Special issue on robust multivariate analysis and classification

Initiation of non-invasive ventilation in amyotrophic lateral sclerosis and clinical practice guidelines: Single-centre, retrospective, descriptive study in a national reference centre

Quantum phase slips in a confined geometry

Factors associated with survival after early at-home NIV initiation in ALS patients

Noninvasive mechanical ventilation assistance in amyotrophic lateral sclerosis: a systematic review

Acute and Sub-Acute Toxicity Studies of Plumeria alba Linn. (Apocynaceae) Hydroalcoholic Extract in Rat

Transthyretin amyloidosis (serine 44) with headache, hearing loss, and peripheral neuropathy

Hyponatremia in Preterm Neonates: Not a Benign Condition

Effects of non-invasive ventilation on objective sleep and nocturnal respiration in patients with amyotrophic lateral sclerosis

Characterization of mu, kappa, and delta opioid binding in amphibian whole brain tissue homogenates.

NIV@Home: a pilot randomized controlled trial of in-home noninvasive ventilation initiation compared to a single-day admission model

Defining successful non-invasive ventilation initiation: Data from a real-life cohort

Giving Breath to Motor Neurons: Noninvasive Mechanical Ventilation Slows Disease Progression in Amyotrophic Lateral Sclerosis

Predictors for successful non-invasive ventilation in patients with neuralgic amyotrophy and phrenic nerve involvement

Effect to prognosis by early or late use of noninvasive positive pressure ventilation in patients with amy- otrophic lateral sclerosis

Unstable control of breathing can lead to ineffective noninvasive ventilation in amyotrophic lateral sclerosis

Continuous noninvasive ventilatory support outcomes for patients with neuromuscular disease: a multicenter data collaboration

Partnership at the forefront of change: documenting the transformation of child and youth mental health services in quebec.

Long term non-invasive ventilation in the community for patients with musculoskeletal disorders: 46 year experience and review

Initiation of Chronic Non-invasive Ventilation

Delivery of noninvasive ventilation to people living with motor neuron disease in the UK